RAC 2.92% $1.94 race oncology ltd

Ann: Race Initiates FTO Melanoma Preclinical Study, page-39

  1. 2,460 Posts.
    lightbulb Created with Sketch. 354
    Thanks @IndexInvestor and @IronMike94. Makes sense.

    I'm expecting this announcement to be sold down. Kind of just informs most long-term investors what they already knew, to a certain degree, but puts the details about the path forward of FTO. Like others have said, is another piece of the puzzle with the real insights to come later on.

    Wonder how the other 2 announcements will look...
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.